Exploration of eJaculatory Anatomy Concept Study (EJAC Study)
Study of the Biomechanical Anatomy of Ejaculation
1 other identifier
interventional
3
1 country
1
Brief Summary
Ejaculatory dysfunctions (ED) are an important cause of postoperative dissatisfaction, which lead to a decrease in the intensity of orgasms in 50% of patients. ED is a cause for concern for almost a third of patients who need surgery. Surgical techniques have been developed to limit the occurrence of postoperative ED, but their results remain heterogeneous. There are very few studies on the biomechanical anatomy of ejaculation. Ejaculation is a complex phenomenon involving different structures and in particular the Veru Montanum. This is the key element in the emission of ejaculate within the prostatic urethra. In addition, there is a structure located in the resection zone of the prostate adenoma. It has therefore been suggested that its resection was a primary source of ED. A single observational study carried out in by Gil Vernet et al in 1994 evaluated on a single healthy 18-year-old volunteer the ejaculatory mechanism of expulsion using an endorectal probe recording the movements of the prostate, the bladder neck and of the proximal urethra during ejaculation. A contemporary study of the biomechanics of the ejaculatory expulsion phase could confirm and improve understanding of the involvement of anatomical structures. The results of our study aim to adapt surgical techniques aimed at limiting the risk of postoperative ED.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2022
CompletedStudy Start
First participant enrolled
December 12, 2022
CompletedFirst Posted
Study publicly available on registry
December 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 9, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 9, 2023
CompletedMarch 6, 2026
January 1, 2023
28 days
November 10, 2022
March 4, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Peri-urethral muscle contraction
Qualitative description of peri-urethral muscle contraction according to ultrasound videos analysis
At Day 0
Urethra, bladder neck and prostate movements
Qualitative description of movements of the urethra, bladder neck and prostate according to ultrasound videos analysis
At Day 0
Sperm flow within the prostatic urethra
Qualitative description of sperm flow within the prostatic urethra according to ultrasound videos analysis
At Day 0
Spermatic fluid via the ejaculatory ducts
Qualitative description of the expulsion and flow of spermatic fluid via the ejaculatory ducts according to urethroscopy videos analysis
At Day 6
Veru montanum mobility and urethral contraction.
Qualitative description of veru montanum mobility and urethral contraction according to urethroscopy videos analysis
At Day 6
Study Arms (1)
Study intervention
EXPERIMENTALTransrectal ultrasound and Urethroscopy
Interventions
Examinations for observation of the pre, per and post-ejaculatory phases
Examinations for observation of the pre, per and post-ejaculatory phases
Eligibility Criteria
You may qualify if:
- Affiliated subject or beneficiary of a social security scheme
- Subject agreeing to participate and having signed the free, informed consent.
You may not qualify if:
- Subject with ejaculatory dysfunction
- Subject with urinary dysfunction
- History of urinary or penile surgery
- Subject with untreated urinary tract infection
- History of chronic prostatitis
- Pathology making it impossible to introduce the endorectal probe or the ureteroscope
- History of colorectal inflammatory disease
- Recent intake (within 30 days) of drugs known to interfere with ejaculation
- History of intolerance or allergy to any of the drugs used in the study
- Subject participating in another clinical study
- Adults under guardianship, curatorship or other legal protection; deprived of liberty by judicial or administrative decision; Hospitalized without consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clinique Pasteurlead
Study Sites (1)
Clinique Pasteur
Toulouse, France
Related Publications (1)
Pradere B, Uleri A, Bruguiere E, Misrai V. Exploration of the Ejaculatory Anatomy Concept: The EJAC Study. Eur Urol. 2025 Aug 25:S0302-2838(25)00451-8. doi: 10.1016/j.eururo.2025.08.001. Online ahead of print.
PMID: 40858456RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Benjamin Pradère, MD
Clinique La Croix du Sud
- STUDY DIRECTOR
Eric Bruguière, MD
Clinique Pasteur
- STUDY DIRECTOR
Vincent Misraï, MD
Clinique Pasteur
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 10, 2022
First Posted
December 14, 2022
Study Start
December 12, 2022
Primary Completion
January 9, 2023
Study Completion
January 9, 2023
Last Updated
March 6, 2026
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share